Award

82403075

Funder: National Natural Science Foundation of China

Funded outputs count: 5

Funder award ID: 82403075

OpenAlex ID: G2338318348

Mitochondrial Metabolic Reprogramming in Glioma: Mechanisms of Tumorigenesis and Implications for Clinical Therapy

2026 · Liangqi Jiang, Mingrui Li, et al. · CNS Neuroscience & Therapeutics

LRRC4 Orchestrates AP2A1‐Containing Clathrin‐Coated Vesicles to Disrupt Mitochondrial Cristae and Restrict Glioblastoma Progression

2026 · Yang Li, Cheng Huang, et al. · Advanced Science

Mitochondrial electron transport chain gene-based prognostic model identifies SDHB as a key regulator of low-grade glioma progression and therapeutic target

2025 · Yang Li, Qing Liu, et al. · Cancer Cell International · 1

MitCOM-based prognostic model identifies GLUD1 as a key suppressor of glioblastoma growth and invasion through regulation of mitochondrial structure and metabolism

2025 · Yang Li, Chaoying Qin, et al. · Cancer Cell International · 2

ER stress-related mitochondrial protein-coding gene risk model and in vitro experiments unveil OMA1 as a novel prognostic and therapeutic biomarker for low-grade glioma

2025 · Chaoying Qin, Yabo Feng, et al. · Life Sciences · 1